Swati Prakash

Lucknow, UP, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Diabetic cardiomyopathy and COVID-19: intersecting pathways and amplified cardiovascular risk.

Diabetic cardiomyopathy and COVID-19: intersecting pathways and amplified cardiovascular risk.

Journal: Frontiers in pharmacology
Published: August 10, 2025

Association between sleep disturbance and metabolic dysfunctions in adipose tissue: Insights into melatonin's role.

Association between sleep disturbance and metabolic dysfunctions in adipose tissue: Insights into melatonin's role.

Journal: Biochemical and biophysical research communications
Published: January 23, 2025

Chronic Inflammation and Cancer: Key Pathways and Targeted Therapies.

Chronic Inflammation and Cancer: Key Pathways and Targeted Therapies.

Journal: Cancer investigation
Published: December 08, 2024

Tetramethylpyrazine alleviates diabetic nephropathy through the activation of Akt signalling pathway in rats.

Tetramethylpyrazine alleviates diabetic nephropathy through the activation of Akt signalling pathway in rats.

Journal: European journal of pharmacology
Published: September 09, 2019

Amelioration of diet-induced metabolic syndrome and fatty liver with sitagliptin via regulation of adipose tissue inflammation and hepatic Adiponectin/AMPK levels in mice.

Amelioration of diet-induced metabolic syndrome and fatty liver with sitagliptin via regulation of adipose tissue inflammation and hepatic Adiponectin/AMPK levels in mice.

Journal: Biochimie
Published: July 08, 2019

Tetramethylpyrazine prevents diabetes by activating PI3K/Akt/GLUT-4 signalling in animal model of type-2 diabetes.

Tetramethylpyrazine prevents diabetes by activating PI3K/Akt/GLUT-4 signalling in animal model of type-2 diabetes.

Journal: Life sciences
Published: May 28, 2019

Pterostilbene Decreases Cardiac Oxidative Stress and Inflammation via Activation of AMPK/Nrf2/HO-1 Pathway in Fructose-Fed Diabetic Rats.

Pterostilbene Decreases Cardiac Oxidative Stress and Inflammation via Activation of AMPK/Nrf2/HO-1 Pathway in Fructose-Fed Diabetic Rats.

Journal: Cardiovascular drugs and therapy
Published: March 21, 2018

Promising therapeutic potential of pterostilbene and its mechanistic insight based on preclinical evidence.

Promising therapeutic potential of pterostilbene and its mechanistic insight based on preclinical evidence.

Journal: European journal of pharmacology
Published: April 26, 2016
Showing 1-8 of 8

Last Updated: 09/26/2026